Teaching Old Drugs New Tricks: Statins for COVID-19? #MMPMID32755604
Fajgenbaum DC; Rader DJ
Cell Metab 2020[Aug]; 32 (2): 145-147 PMID32755604show ga
The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large observational study of hospitalized COVID-19 patients. Given the widespread availability, low cost, and safety of statins, this promising result should be further investigated in randomized controlled trials.